1. Home
  2. RNXT vs MOVE Comparison

RNXT vs MOVE Comparison

Compare RNXT & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • MOVE
  • Stock Information
  • Founded
  • RNXT 2012
  • MOVE 2018
  • Country
  • RNXT United States
  • MOVE United States
  • Employees
  • RNXT N/A
  • MOVE N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • RNXT Health Care
  • MOVE Health Care
  • Exchange
  • RNXT Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • RNXT 30.0M
  • MOVE 25.9M
  • IPO Year
  • RNXT 2021
  • MOVE 2021
  • Fundamental
  • Price
  • RNXT $1.27
  • MOVE $5.98
  • Analyst Decision
  • RNXT Strong Buy
  • MOVE Buy
  • Analyst Count
  • RNXT 2
  • MOVE 1
  • Target Price
  • RNXT $6.50
  • MOVE $30.00
  • AVG Volume (30 Days)
  • RNXT 118.6K
  • MOVE 84.2K
  • Earning Date
  • RNXT 11-13-2024
  • MOVE 11-14-2024
  • Dividend Yield
  • RNXT N/A
  • MOVE N/A
  • EPS Growth
  • RNXT N/A
  • MOVE N/A
  • EPS
  • RNXT N/A
  • MOVE N/A
  • Revenue
  • RNXT N/A
  • MOVE $902,000.00
  • Revenue This Year
  • RNXT N/A
  • MOVE N/A
  • Revenue Next Year
  • RNXT N/A
  • MOVE $545.31
  • P/E Ratio
  • RNXT N/A
  • MOVE N/A
  • Revenue Growth
  • RNXT N/A
  • MOVE N/A
  • 52 Week Low
  • RNXT $0.68
  • MOVE $2.80
  • 52 Week High
  • RNXT $2.35
  • MOVE $12.75
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 52.77
  • MOVE 60.59
  • Support Level
  • RNXT $1.21
  • MOVE $5.75
  • Resistance Level
  • RNXT $1.55
  • MOVE $6.97
  • Average True Range (ATR)
  • RNXT 0.12
  • MOVE 0.52
  • MACD
  • RNXT -0.02
  • MOVE 0.05
  • Stochastic Oscillator
  • RNXT 32.20
  • MOVE 54.36

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: